Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey)

Journal of the American College of Cardiology

Volumn 56, Issue 23, 2010, Pages 1930-1936

  Wu, Cho Kai ^a,b   Lin, Jou Wei ^a,b   Caffrey, James L ^c   Chang, Man Huei ^d   Hwang, Juey Jen ^a,b   Lin, Yu Sheng ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c University of North   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Cystatin C; Glomerular filtration rate; Nutrition survey; Survival analysis

Indexed keywords

CREATININE; CYSTATIN C;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHILD; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; CREATININE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NUTRITION SURVEYS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 78649366808     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.04.069     Document Type: Article

References (35)

1. L.F. Fried, R. Katz, and M.J. Sarnak Kidney function as a predictor of noncardiovascular mortality J Am Soc Nephrol 16 2005 3728 3735
2. M.G. Shlipak, C.L. Wassel Fyr, and G.M. Chertow Cystatin C and mortality risk in the elderly: the health, aging, and body composition study J Am Soc Nephrol 17 2006 254 261
3. D.J. Newman, H. Thakkar, and R.G. Edwards Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine Kidney Int 47 1995 312 318
4. K. Ishida, H. Ishida, and M. Narita Factors affecting renal function in 119 985 adults over three years QJM 94 2001 541 550
5. J.P. Kassirer Clinical evaluation of kidney functionglomerular function N Engl J Med 285 1971 385 389
6. M.G. Shlipak, R. Katz, and M.J. Sarnak Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 2006 237 246
7. N. Taglieri, D.J. Fernandez-Berges, and W. Koenig Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome Atherosclerosis 209 2010 300 305
8. E.D. Poggio, P.C. Nef, and X. Wang Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients Am J Kidney Dis 46 2005 242 252 (Pubitemid 41040352)
9. A. Kottgen, E. Selvin, and L.A. Stevens Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 51 2008 385 394
10. D.J. Newman Cystatin C Ann Clin Biochem 39 2002 89 104
11. Centers for Disease Control and Prevention Plan and operation of the Third National Health and Nutrition Examination Survey, 198894 Series 1: programs and collection procedures Vital Health Stat 1 1994 1 407
12. G. Mancia, and G. Grassi Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road? J Am Soc Nephrol 16 Suppl 1 2005 S74 S77
13. E.W. Gunter, B.L. Lewis, and S.M. Koncikowski Laboratory Methods used for the Third National Health and Nutrition Examination Survey (NHANES III), 19881994 CD-ROM 6-0178, NHANES III Reference Manuals and Reports 1996 Centers for Disease Control and Prevention Hyattsville, MD
14. J. Coresh, B.C. Astor, and T. Greene Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
15. J. Coresh, E. Selvin, and L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2047 (Pubitemid 350074801)
16. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
17. E. Selvin, J. Manzi, and L.A. Stevens Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 19881994, 19992004 Am J Kidney Dis 50 2007 918 926
18. Centers for Disease Control and Prevention (CDC) Third National Health and Nutrition Examination Survey (NHANES III) linked mortality file restricted-use file layout 2009 US Department of Health and Human Services, Centers for Disease Control and Prevention Hyattsville, MD http://www.cdc.gov/ nchs/data/datalinkage/file-layout-nh3.pdf Accessed October 7, 2009
19. R.J. Klein, and C.A. Schoenborn Age Adjustment Using the 2000 Projected US Population: Healthy People Statistical Notes No. 20 2001 National Center for Health Statistics Hyattsville, MD
20. L.A. Stevens, and A.S. Levey Chronic kidney disease in the elderlyhow to assess risk N Engl J Med 352 2005 2122 2124
21. H. Finney, D.J. Newman, and C.P. Price Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance Ann Clin Biochem 37 2000 49 59
22. M. Fricker, P. Wiesli, and M. Brandle Impact of thyroid dysfunction on serum cystatin C Kidney Int 63 2003 1944 1947
23. N. Taglieri, W. Koenig, and J.C. Kaski Cystatin C and cardiovascular risk Clin Chem 55 2009 1932 1943
24. G.K. Sukhova, G.P. Shi, and D.I. Simon Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells J Clin Invest 102 1998 576 583
25. J. Leung-Tack, C. Tavera, and M.C. Gensac Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg Exp Cell Res 188 1990 16 22
26. E.L. Knight, J.C. Verhave, and D. Spiegelman Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Kidney Int 65 2004 1416 1421
27. M.G. Shlipak, M.J. Sarnak, and R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060
28. J.H. Ix, M.G. Shlipak, and G.M. Chertow Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2007 173 179
29. B.C. Astor, A.S. Levey, and L.A. Stevens Method of glomerular filtration rate estimation affects prediction of mortality risk J Am Soc Nephrol 20 2009 2214 2222
30. M.C. Odden, G.M. Chertow, and L.F. Fried Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study Am J Epidemiol 164 2006 1180 1189
31. K. Yaffe, K. Lindquist, and M.G. Shlipak Cystatin C as a marker of cognitive function in elders: findings from the health ABC study Ann Neurol 63 2008 798 802
32. J. Coresh, B.C. Astor, and G. McQuillan Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate Am J Kidney Dis 39 2002 920 929
33. L. Manetti, E. Pardini, and M. Genovesi Thyroid function differently affects serum cystatin C and creatinine concentrations J Endocrinol Invest 28 2005 346 349
34. S.J. Hwang, Q. Yang, and J.B. Meigs A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study BMC Med Genet 8 Suppl 1 2007 S10
35. C.Y. Campbell, W. Clarke, H. Park, N. Haq, B.B. Barone, and D.J. Brotman Usefulness of cystatin C and prognosis following admission for acute heart failure Am J Cardiol 104 2009 389 392